nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Degarelix—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Degarelix—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Degarelix—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Degarelix—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Degarelix—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Degarelix—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Degarelix—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Degarelix—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Degarelix—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Degarelix—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Degarelix—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Degarelix—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Degarelix—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Degarelix—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Degarelix—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Degarelix—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Degarelix—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Degarelix—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Degarelix—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Degarelix—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Degarelix—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Degarelix—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Degarelix—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00239	CcSEcCtD
Degarelix—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Degarelix—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Degarelix—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Degarelix—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Degarelix—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Degarelix—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Degarelix—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Degarelix—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Degarelix—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Degarelix—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Degarelix—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Degarelix—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Degarelix—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Degarelix—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Degarelix—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Degarelix—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Degarelix—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Degarelix—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Degarelix—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Degarelix—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Degarelix—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Degarelix—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Degarelix—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Degarelix—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Degarelix—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Degarelix—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Degarelix—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Degarelix—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Degarelix—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Degarelix—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Degarelix—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Degarelix—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Degarelix—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Degarelix—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00209	CcSEcCtD
Degarelix—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00209	0.00209	CcSEcCtD
Degarelix—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00209	0.00209	CcSEcCtD
Degarelix—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00209	0.00209	CcSEcCtD
Degarelix—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Degarelix—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Degarelix—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Degarelix—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00204	CcSEcCtD
Degarelix—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Degarelix—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Degarelix—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Degarelix—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.002	0.002	CcSEcCtD
Degarelix—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00199	CcSEcCtD
Degarelix—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00198	CcSEcCtD
Degarelix—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Degarelix—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Degarelix—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Degarelix—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Degarelix—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Degarelix—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00193	0.00193	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00192	0.00192	CcSEcCtD
Degarelix—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00191	CcSEcCtD
Degarelix—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00191	CcSEcCtD
Degarelix—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Degarelix—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00189	CcSEcCtD
Degarelix—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00188	CcSEcCtD
Degarelix—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00187	0.00187	CcSEcCtD
Degarelix—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Degarelix—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Degarelix—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Degarelix—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Degarelix—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Degarelix—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Degarelix—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Degarelix—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Degarelix—Pain—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Degarelix—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Degarelix—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00182	CcSEcCtD
Degarelix—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Degarelix—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Degarelix—Pain—Montelukast—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Degarelix—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Degarelix—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Degarelix—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Degarelix—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Degarelix—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Degarelix—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Degarelix—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Degarelix—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Degarelix—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Degarelix—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Degarelix—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Degarelix—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Degarelix—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Degarelix—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Degarelix—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Degarelix—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Degarelix—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Degarelix—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Degarelix—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Degarelix—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Degarelix—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Degarelix—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Degarelix—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Degarelix—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Degarelix—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.00169	CcSEcCtD
Degarelix—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Degarelix—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Degarelix—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Degarelix—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Degarelix—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Degarelix—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Degarelix—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Degarelix—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Degarelix—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Degarelix—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Degarelix—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Degarelix—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Degarelix—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Degarelix—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Degarelix—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Degarelix—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Degarelix—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Degarelix—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Degarelix—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Degarelix—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Degarelix—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Degarelix—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Degarelix—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Degarelix—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Degarelix—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Degarelix—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Degarelix—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Degarelix—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Degarelix—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00144	CcSEcCtD
Degarelix—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Degarelix—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Degarelix—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Degarelix—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Degarelix—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Degarelix—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Degarelix—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Degarelix—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Degarelix—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Degarelix—Rash—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Headache—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Degarelix—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Degarelix—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Degarelix—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Degarelix—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Degarelix—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Degarelix—Rash—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Degarelix—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Degarelix—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Degarelix—Depression—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Degarelix—Headache—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Degarelix—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Degarelix—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Degarelix—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Degarelix—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Degarelix—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Degarelix—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Degarelix—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Degarelix—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Degarelix—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Degarelix—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Degarelix—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Degarelix—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Degarelix—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Degarelix—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Degarelix—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Degarelix—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Degarelix—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Degarelix—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Degarelix—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Degarelix—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Degarelix—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Degarelix—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Degarelix—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000994	0.000994	CcSEcCtD
Degarelix—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000976	0.000976	CcSEcCtD
Degarelix—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000961	0.000961	CcSEcCtD
Degarelix—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000958	0.000958	CcSEcCtD
Degarelix—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000957	0.000957	CcSEcCtD
Degarelix—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000934	0.000934	CcSEcCtD
Degarelix—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000924	0.000924	CcSEcCtD
Degarelix—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000894	0.000894	CcSEcCtD
Degarelix—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000881	0.000881	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000875	0.000875	CcSEcCtD
Degarelix—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000871	0.000871	CcSEcCtD
Degarelix—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000857	0.000857	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000845	0.000845	CcSEcCtD
Degarelix—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000829	0.000829	CcSEcCtD
Degarelix—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000821	0.000821	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000817	0.000817	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00077	0.00077	CcSEcCtD
Degarelix—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000769	0.000769	CcSEcCtD
Degarelix—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000764	0.000764	CcSEcCtD
Degarelix—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000735	0.000735	CcSEcCtD
Degarelix—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.000733	CcSEcCtD
Degarelix—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.000733	CcSEcCtD
Degarelix—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000729	0.000729	CcSEcCtD
Degarelix—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000728	0.000728	CcSEcCtD
Degarelix—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000723	0.000723	CcSEcCtD
Degarelix—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000696	0.000696	CcSEcCtD
Degarelix—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000691	0.000691	CcSEcCtD
Degarelix—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000691	0.000691	CcSEcCtD
Degarelix—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000671	0.000671	CcSEcCtD
Degarelix—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000668	0.000668	CcSEcCtD
Degarelix—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000668	0.000668	CcSEcCtD
Degarelix—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000623	0.000623	CcSEcCtD
Degarelix—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000606	CcSEcCtD
Degarelix—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000598	0.000598	CcSEcCtD
Degarelix—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000578	0.000578	CcSEcCtD
Degarelix—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000559	0.000559	CcSEcCtD
Degarelix—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000537	CcSEcCtD
Degarelix—Rash—Prednisone—chronic obstructive pulmonary disease	0.000533	0.000533	CcSEcCtD
Degarelix—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000532	CcSEcCtD
Degarelix—Headache—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000529	CcSEcCtD
Degarelix—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000502	0.000502	CcSEcCtD
